EZH2 and familial pancreatic carcinoma: Next, we confirmed that the EZH2-TPH1-5-HT7 axis is a useful therapeutic target against drug-resistant pancreatic cancer, using an in vivo tumor model in which PANC-1 cells were subcutaneously transplanted.